Raffles Medical H1 profit rises 0.5% to S$59.9 million; chairman says will consider M&A
DeeperDive is a beta AI feature. Refer to full articles for the facts.
RAFFLES Medical Group posted a 0.5 per cent rise in net profit to S$59.9 million for its first half ended Jun 30, from S$59.5 million in the previous corresponding period.
The growth in profit came despite a 9.5 per cent decline in revenue – to S$370.9 million from S$409.7 million in the year-ago period.
Manpower costs fell alongside Covid-related activities, the private healthcare provider said on Monday (Jul 31). The group also recorded a year-on-year fall in net reinsurance expenses, and a smaller impairment loss on trade receivables.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report